Efficacy of Gemfibrozil as an adjust therapy in obsessive compulsive disorder, a randomized clinical trial with medication control
Phase 3
Recruiting
- Conditions
- Obsessives-Compulsive disorder.Obsessive-compulsive personality disorderF60.5
- Registration Number
- IRCT20230211057389N1
- Lead Sponsor
- Karaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Having DSM-V diagnostic criteria for obsessive-compulsive disorder
ages between 18 to 60
Exclusion Criteria
Abuse of drugs and medicine except nicotine and caffeine
Known case of Mental Retardation
Presence of other mental disorders
The presence of psychotic manifestations
Presence of significant medical or neurological disease (advanced kidney disease, CKD, liver disease, cardiovascular disease, and hypertension) and history of gallstones
Concomitant use of warfarin
Concomitant use of insulin
Concomitant use of Statin group
Concomitant use of niacin group drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score of Yale-Brown Obsessive-Compulsive scale. Timepoint: Second, fourth and eighth week. Method of measurement: Yale-Brown Obsessive-Compulsive scale.
- Secondary Outcome Measures
Name Time Method